Shionogi Partners with Maze Therapeutics for MZE001’s Rights to Treat Pompe Disease
Shots: Following the completion of transaction and expiry of 30-day waiting period...
Shots: Following the completion of transaction and expiry of 30-day waiting period...
Shots: Metaphore & Flagship Pioneering have teamed up with Novo Nordisk to dev...
Shots: ARTBIO and Nucleus RadioPharma have entered into a strategic manufacturing...
Shots: IRLAB and MSRD (member of Otsuka Pharmaceutical) have collaborated to devel...
Shots: BioVersys and GSK have expanded their strategic collaboration to accelerate...
Shots: Astellas reported that its subsidiary, Xyphos Biosciences, & Poseida ha...
Incisive News in 3 Shots.